Lilly Mark

Lilly Mark is an accomplished research scientist with extensive experience in preclinical and in vivo studies focusing on pain, antimicrobial research, and analgesia. Currently serving as a Research Scientist at Insmed Incorporated since April 2019, Lilly previously held positions at TAXIS Pharmaceuticals as Associate Director and at Pfizer as Research Scientist II, where responsibilities included leading pain-related studies, managing animal models, and authoring multiple research protocols. With a solid foundation in animal sciences from Vanier College, Lilly's career spans over two decades across prominent organizations such as Schering-Plough and Purdue Pharma, along with early experience as an Animal Technician and Research Intern. Skilled in microsurgeries and data management, Lilly has contributed significantly to advancements in neuroscience and pharmacology.